期刊文献+

宫颈癌组织中CCR7及CXCR4的表达及与临床病理特征的关系 被引量:3

Expression of CCR7 and CXCR4 in cervical cancer and its relationship with clinicopathological features
原文传递
导出
摘要 目的探讨CC族趋化因子受体7(CCR7)及CXC族趋化因子受体4(CXCR4)在宫颈癌组织中的表达情况及与临床病理特征的关系。方法选取2015年2月至2016年2月间深圳市蛇口人民医院收治的行子宫切除术的82例宫颈癌患者为观察组,另选取同期体检筛查的26例宫颈上皮组织阴性者为对照组。采用免疫组化SP法检测两组CCR7和CXCR4的表达,并分析CCR7和CXCR4的表达与临床病理特征的关系。结果观察组中CCR7的阳性表达率为58.5%,明显高于对照组的26.9%,观察组中CXCR4的阳性表达率为52.4%,明显高于对照组的19.2%,差异均有统计学意义(均P<0.05)。宫颈癌组织中,CCR7的阳性表达与FIGO分期、肿瘤直径、间质浸润深度及淋巴结转移均有关,差异均有统计学意义(均P<0.05),与年龄、组织病理类型、阴道浸润及子宫旁浸润无关,差异均无统计学意义(均P>0.05)。CXCR4的阳性表达与淋巴结转移有关,差异有统计学意义(P<0.05),与年龄、FIGO分期、组织病理类型、肿瘤直径、间质浸润深度、阴道浸润及子宫旁浸润无关,差异均无统计学意义(均P>0.05)。宫颈癌组织中CCR7与CXCR4的表达呈正相关,差异有统计学意义(P<0.05)。结论 CCR7及CXCR4在宫颈癌组织中呈高表达,两者均在宫颈癌淋巴转移中发挥重要作用,与宫颈癌患者预后效果密切相关。 Objective To investigate the expression of CC chemokine receptor 7(CCR7) and CXC chemokine receptor 4(CXCR4) in cervical cancer and analyze its the relationship with clinicopathological features.Methods A total of 82 patients with cervical cancer who underwent hysterectomy at Shekou People's Hospital from February 2015 to February 2016 were selected as the observation subjects.Twenty-six individuals with negative cervical epithelial test during the physical examination were selected as the control group.Using S-P immunohistochemical method,the expressions of CCR7 and CXCR4 were detected and the relationship between the expression of CCR7 or CXCR4 and clinicopathological features were analyzed.Results The positive expression rate of CCR7 was 58.5 % for the observation group,which was significantly higher than 26.9 % of the control group and the positive expression rate of CXCR4 was 52.4 % for the observation group,which was significantly higher than19.2 % of the control group(all P0.05).In cervical cancer tissues,the positive expression of CCR7 was associated with FIGO stage,tumor diameter,depth of interstitial infiltration and lymph node metastasis(all P0.05) rather than age,histopathological type,vaginal infiltration and uterine infiltration(all P0.05).The positive expression of CXCR4 was associated with lymph node metastasis(P0.05) rather than age,FIGO stage,histopathological type,tumor diameter,interstitial infiltration depth,vaginal infiltration and uterine infiltration(all P0.05).There was a positive correlation between the expression of CCR7 and CXCR4(P0.05).Conclusion CCR7 and CXCR4 are highly expressed in cervical cancer tissues and both play an important role in lymph node metastasis of cervical cancer,and they were closely related to the prognosis of cervical cancer.
出处 《中国肿瘤临床与康复》 2017年第9期1052-1056,共5页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 深圳市科技计划项目(JCYJ20150403093555011)
关键词 宫颈肿瘤 CCR7 CXCR4 病理特征 Cervical neoplasms CCR7 CXCR4 Pathological features
  • 相关文献

参考文献9

二级参考文献111

  • 1彭彦.p16与p53基因表达在非小细胞肺癌早期诊断及预后判断中的临床意义[J].实用医技杂志,2008,15(15):1909-1911. 被引量:1
  • 2崔友红,卢玉波,杨宏英.宫颈癌微转移的研究现状[J].现代肿瘤医学,2008,16(11):1998-2001. 被引量:4
  • 3张建平,谢幸,吕卫国.趋化因子与肿瘤的定向转移[J].国外医学(肿瘤学分册),2005,32(5):351-354. 被引量:8
  • 4Augusto P, Javier FM, Victoria R, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer [ J ]. Gynecol Oncol 2007,105:604 - 608.
  • 5du Bois A, Reuss A, Harter P, et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospect ely randomized phase Ⅲ multicenter trials[ J ]. J Clin Oncol, 2010,28(10) :1733 - 1739.
  • 6Timmers PJ, Zwinderman AH, Coens C, et al. Understanding the problem of inadequately staging early ovarian cancer[J]. Eur J Cancer,2010, 46(5) :880 -884.
  • 7Zanetta G, Rota S, Chiari S, et al. The accuracy of staging: an important prognostic determinator in stage l ovarian carcinoma[J]. Annals of Oncology, 1998,9 : 1097 - 1101.
  • 8Heintz A, Odicino F, Maisnneuve P, et al. Carcinoma of the ovary 25^th annual report on the results of treatment of gynecological cancer [J]. Int J Gynecol Obstet, 2003,83( 1 ) :135 - 166.
  • 9Edgar P, Hans-Joachim L, Gavin S, et al. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system [ J ]. European Journal of Obstetrics & Gynecology and Reproducte Biology ,2009,143 ( 1 ) :69 - 74.
  • 10Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage Ⅲ after systematic lymphadenectomy have similar survival to stage Ⅰ/Ⅱ patients and superior survival to other stage m patients [ J ]. Cancer, 1998,83 : 1555 - 1560.

共引文献51

同被引文献45

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部